Skip to content
Screener

Achieve Life Sciences ACHV Q2 2025 earnings

Reported August 7, 2025 · Before market open

EPS-$0.37In line
EPS estimate-$0.37

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$10.6M
EPS estimate-$0.20

Financials

Q2 2025

Income statement

See full
Net income-$12.7M-50.3%
EPS (diluted)-$0.37-48.0%

Balance sheet

See full
Cash & equivalents$51.9M+252%
Total debt$1.3M-85.3%
Total equity$41.7M-1.5%
Total assets$58.9M-9.0%

Cash flow

See full
Operating cash flow-$9.1M-84.3%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$132.15M-18.1%
Enterprise value$81.58M-47.5%

Returns & leverage

See full
Return on equity-120.1%+18.5pp
Debt / equity0×-0.2×
Current ratio6.6×+2.1×

FAQ

When did Achieve Life Sciences report Q2 2025 earnings?
Achieve Life Sciences (ACHV) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Achieve Life Sciences's Q2 2025 revenue and EPS?
Achieve Life Sciences reported eps of $-0.37 for Q2 2025.
Did Achieve Life Sciences beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.37 by $0.00.
How did Achieve Life Sciences's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 48.0% from $-0.25.
Where can I find Achieve Life Sciences's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-104569) and the 10-Q periodic report (0000950170-25-104571) directly on SEC EDGAR. The filing index links above go to sec.gov.